Skip to contentDEERFIELD MANAGEMENT CO /NY — ALTIRIS INC insider: 335 transactions · InsiderLensDEERFIELD MANAGEMENT CO /NY
- Director by deputization at Acutus Medical, Inc. · on record since Jun 20, 2023
- 10% owner at Nuvalent, Inc. · on record since Jun 16, 2023
- 10% owner at Deerfield Healthcare Technology Acquisitions Corp. · on record since Jun 12, 2023
- Director by Deputization at Deerfield Healthcare Technology Acquisitions Corp. · on record since Jun 12, 2023
- 10% owner at PAR PHARMACEUTICAL COMPANIES, INC. · on record since Feb 1, 2007
- 10% owner at DA32 Life Science Tech Acquisition Corp. · on record since Aug 1, 2023
- Director by Deputization at DA32 Life Science Tech Acquisition Corp. · on record since Aug 1, 2023
- Director at NOVELLUS SYSTEMS INC · on record since Sep 14, 2016
- 10% owner at NOVELLUS SYSTEMS INC · on record since Sep 14, 2016
- Director at Chardan Healthcare Acquisition Corp. · on record since Mar 19, 2024
- *Director by Deputization at Chardan Healthcare Acquisition Corp. · on record since Mar 19, 2024
- 10% owner at Chardan Healthcare Acquisition Corp. · on record since Mar 19, 2024
- 10% owner at AdaptHealth Corp. · on record since Mar 12, 2024
- *Possible Member of 10% Group at AdaptHealth Corp. · on record since Mar 12, 2024
- 10% owner at FRACTYL HEALTH, INC. · on record since Feb 8, 2024
- Possible Member of 10% Group at FRACTYL HEALTH, INC. · on record since Feb 1, 2024
- 10% owner at Bicara Therapeutics Inc. · on record since Sep 17, 2024
- *Possible Member of 10% Group at Bicara Therapeutics Inc. · on record since Sep 12, 2024
- 10% owner at ARS Pharmaceuticals, Inc. · on record since Nov 13, 2024
- 10% owner at INSPIRE PHARMACEUTICALS INC · on record since May 2, 2007
- 10% owner at CORAUTUS GENETICS INC · on record since Aug 24, 2007
- 10% owner at DYNAVAX TECHNOLOGIES CORP · on record since Jul 23, 2007
- 10% owner at DUSA PHARMACEUTICALS INC · on record since Nov 27, 2007
- 10% owner at EMAGEON INC · on record since Nov 27, 2007
- 10% owner at ANADYS PHARMACEUTICALS INC · on record since Oct 25, 2007
- 10% owner at ARENA PHARMACEUTICALS INC · on record since Oct 23, 2007
- Director by Deputization at Nuvalent, Inc. · on record since Jun 16, 2023
- 10% owner at NeurogesX Inc · on record since Mar 31, 2008
- 10% owner at XCYTE THERAPIES INC · on record since Mar 14, 2008
- 10% owner at NITROMED INC · on record since May 6, 2008
- 10% owner at SALIX PHARMACEUTICALS LTD · on record since Oct 21, 2008
- 10% owner at NeuroMetrix, Inc. · on record since Dec 5, 2008
- 10% owner at NxStage Medical, Inc. · on record since Jun 19, 2009
- 10% owner at MGI PHARMA INC · on record since Jan 8, 2004
- Director at Larimar Therapeutics, Inc. · on record since May 20, 2026
- 10% owner at Larimar Therapeutics, Inc. · on record since May 20, 2026
- * Director by Deputization at Larimar Therapeutics, Inc. · on record since May 20, 2026
- 10% owner at Parabilis Medicines, Inc. · on record since Jun 9, 2026
- Possible Member of 10% Group at Parabilis Medicines, Inc. · on record since Jun 9, 2026
- Director at Q32 Bio Inc. · on record since Mar 29, 2018
- Director at AdaptHealth Corp. · on record since Feb 23, 2018
- 10% owner at Aclaris Therapeutics, Inc. · on record since Dec 27, 2018
- Director at Nuvalent, Inc. · on record since Jul 30, 2021
- Director at Oncology Institute, Inc. · on record since Mar 17, 2020
- Director at Deerfield Healthcare Technology Acquisitions Corp. · on record since Jul 22, 2020
- Director at Acutus Medical, Inc. · on record since Aug 12, 2020
- Director at Oncorus, Inc. · on record since Oct 8, 2020
- Director at DA32 Life Science Tech Acquisition Corp. · on record since Jul 27, 2021
- Director at ARS Pharmaceuticals, Inc. · on record since Nov 10, 2022
Insider trading activity of DEERFIELD MANAGEMENT CO /NY
- Transactions on record
- 335
- since Jan 14, 2004
- Open-market buys
- 57
- $49.4M
- Open-market sells
- 167
- $31.6M
- Companies traded
- 36
- last filing Jun 20, 2025
Figures computed from official regulatory filings — methodology.
Companies where DEERFIELD MANAGEMENT CO /NY has traded
- Nuvalent, Inc.10 tx · Jun 20, 2025
- Larimar Therapeutics, Inc.6 tx · $4.4M · May 15, 2025
- Chardan Healthcare Acquisition Corp.7 tx · $657K · Apr 18, 2025
- Acutus Medical, Inc.2 tx · Jul 5, 2022
- Oncology Institute, Inc.11 tx · $100M · Nov 16, 2021
- DA32 Life Science Tech Acquisition Corp.2 tx · $22.5M · Aug 3, 2021
- Revolution Medicines, Inc.6 tx · $10.2M · Feb 18, 2020
- Schrodinger, Inc.3 tx · $4.3M · Feb 10, 2020
- Q32 Bio Inc.4 tx · $7.7M · Dec 27, 2019
Track record of DEERFIELD MANAGEMENT CO /NY
Statistical track record
Free- Open-market buys
- 79
- Last buy
- Nov 12, 2021
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of DEERFIELD MANAGEMENT CO /NY
Co-insiders of DEERFIELD MANAGEMENT CO /NY
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
5 tx · $7.7M · Oct 30, 2019
Acutus Medical, Inc. +6
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 20, 2025 | AwardD | 4,147 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | AwardD | 4,147 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | Award | 2,647 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | Award | 2,647 | 0.00 USD | $0 | SEC |
| May 15, 2025 | AwardD | 19,000 | 0.00 USD | $0 | SEC |
| Apr 18, 2025 | AwardD | 17,600 | 0.00 USD | $0 | SEC |
| Mar 3, 2025 | ExerciseD | -1,611,863 | — | — | SEC |
| Mar 3, 2025 | Exercise | 353,249 | 0.93 USD | $328.5K | SEC |
| Mar 3, 2025 | AwardD | 1,258,614 | — | — | SEC |
| Mar 3, 2025 | AwardD | 1,258,614 | — | — | SEC |
| Mar 3, 2025 | Exercise | 353,249 | 0.93 USD | $328.5K | SEC |
| Mar 3, 2025 | ExerciseD | -1,611,863 | — | — | SEC |
| Jun 16, 2023 | AwardD | 15,000 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | AwardD | 15,000 | 0.00 USD | $0 | SEC |
| May 11, 2023 | AwardD | 8,300 | 0.00 USD | $0 | SEC |
| Jul 5, 2022 | AwardD | 1,889,509 | — | — | SEC |
| Jul 5, 2022 | AwardD | 1,889,509 | — | — | SEC |
| Jun 21, 2022 | AwardD | 20,000 | 0.00 USD | $0 | SEC |
| Jun 21, 2022 | AwardD | 20,000 | 0.00 USD | $0 | SEC |
| Nov 16, 2021 | OtherD | -40 | 0.00 USD | $0 | SEC |
| Nov 16, 2021 | OtherD | 625,000 | — | — | SEC |
| Nov 16, 2021 | BuyD | 50,000 | 1,000.00 USD | $50M | SEC |
| Nov 16, 2021 | Other | 40 | — | — | SEC |
| Nov 16, 2021 | OtherD | -14,887 | 0.00 USD | $0 | SEC |
| Nov 16, 2021 | OtherD | -85,113 | 0.00 USD | $0 | SEC |